Patent Access& Intellectual property& FDA Regulations

A patent is an arrangement of select rights conceded by a sovereign state to an innovator or appointee for a constrained timeframe in return for point by point open divulgence of a creation. An innovation is an answer for a particular mechanical issue and is an item or a procedure. Licenses are a type of protected innovation. Regulatory affairs  is a comparatively new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory Affairs  is involved in the development of new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant regulatory dossiers to health authorities.

  • Lifecycle management of drug products
  • Patents and disputes case studies
  • Identification techniques adulterated and misbranded drugs
  • FDCA (Federal Food, Drug, and Cosmetic Act )
  • Exemption in prescription and OTC drugs
  • Environmental health hazards

Related Conference of Patent Access& Intellectual property& FDA Regulations

September 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Patent Access& Intellectual property& FDA Regulations Conference Speakers

Recommended Sessions

Related Journals

Are you interested in